The collection of the human breast carcinomas used for the evaluation of p110δ levels was consisting of estrogen receptor (ER)- and/or progesterone receptor (PR)- positive, as well as ER-and/or PR-negative tumours whereas all tumours were human epidermal growth factor receptor 2 (HER2) negative. The gene discussed is ESR1; the disease is breast carcinoma.